Orthofuse
A medtech startup developing 'tweakable' 3D-printed titanium implants that allow surgeons to perform intraoperative customization for spinal and orthopedic procedures.
- CEO / Founder
- James Scott
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $3.0M
- Latest Round
- Seed
- Key Investors
- ACF Investors, Cambridge Angels, Empirical Ventures, Avonmore Developments
Technology & Products
Key Products
3D-printed implant systems with re-positionable architectures for trauma and spinal surgery, allowing intraoperative customization.
Technological Advantage
Combines the precision of additive manufacturing with mechanical adjustability, bridging the gap between generic off-the-shelf implants and expensive, slow-to-produce patient-specific custom devices.
Differentiation
Value Proposition
Reduces the need for large inventories of pre-sized implants by providing a 'tweakable' solution that can be adjusted in real-time to fit a patient's unique anatomy, improving surgical precision and patient outcomes in complex cases.
How They Differentiate
Unlike static 3D-printed implants or pre-planned patient-specific devices, Orthofuse offers 'tweakable' intraoperative customization, allowing surgeons to adjust the implant's mechanical properties in real-time during surgery.
Market & Competition
Target Customers
Spinal and orthopedic surgeons, hospitals, and specialized surgical centers.
Industry Verticals
Medical Devices, Orthopedics, Spinal Surgery, Additive Manufacturing (3D Printing)
Competitors
Materialise NV, 3D Systems, Stratasys, Osseus Fusion Systems, Nexxt Spine
Growth & Milestones
Growth Metrics
Transitioning from technical development to regulatory readiness and early-stage clinical evaluations.
Major Milestones
Company founded/incorporated 2024 (ORTHOFUSE LTD, 2 Apr 2024) by James Scott with clinical co-founder ties to Julian Leong/RNOH, Secured £2.2M Seed funding in February 2026 (ACF Investors, Cambridge Angels, Empirical Ventures, Avonmore Developments), Development of proprietary adjustable/3D-printed implant architectures for trauma and spinal procedures, Established clinical research ties with the Royal National Orthopaedic Hospital (RNOH)
Notable Customers
Royal National Orthopaedic Hospital (Clinical Partner)